We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Novel Sequence Analysis Services Improve Pathogen Identification

By LabMedica International staff writers
Posted on 19 Nov 2014
Print article
A set of new-generation sequencing (NGS) services provides unique tools for more effective identification of known and unknown microorganisms, including bacterial, viral, fungal, and protozoan parasite pathogens.

Aperiomics (Ashburn, VA, USA) has now introduced its breakthrough Absolute-NGS Pathogen Detection Platform at the 2014 Annual Meeting of the Association for Molecular Pathology. The unique service addresses the biggest challenge in applying NGS to real-world analysis – making sense of the massive amount of data. Aperiomics, named after the Latin "aperio" meaning to reveal, is rolling out its platform package of 3 NGS services—Absolute-ID, Absolute-Discover, and Absolute-Biome—to provide better tools for rapid identification of known and unknown pathogens.

Absolute-ID is designed to identify known pathogens in virtually any sample. Absolute-Discover addresses the reality that many pathogens have not yet been discovered and many diseases are of unknown etiology. Pathogen identifications have historically been limited by what can be seen under a microscope and what can be cultured in a petri dish, but the Absolute-Discover service can discover new pathogens.

Absolute-Biome is designed to identify all microorganisms present in a given sample. Characterization of a microbial population, or microbiome, gives insight into the health of a human, animal, or environment. Such microbiome studies can be performed over space or time to study the impact of disease, drugs, or environmental changes in a complex system.

From a single test, innovative technology simultaneously tests for multiple pathogens using an unbiased sequencing and genomic analysis approach. The range of samples can include tissue, blood, plant, animal, or environmental. With a novel combination of genomics and informatics, Aperiomics has capitalized on high-throughput NGS and advanced Bayesian statistics to produce faster and better results than culture-based methods and even more accurate results than other molecular-based approaches.

Related Links:

Aperiomics


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.